Cargando…
Key biomarkers and latent pathways of dysferlinopathy: Bioinformatics analysis and in vivo validation
BACKGROUND: Dysferlinopathy refers to a group of muscle diseases with progressive muscle weakness and atrophy caused by pathogenic mutations of the DYSF gene. The pathogenesis remains unknown, and currently no specific treatment is available to alter the disease progression. This research aims to in...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530905/ https://www.ncbi.nlm.nih.gov/pubmed/36203997 http://dx.doi.org/10.3389/fneur.2022.998251 |